Proteasome activity assay

TJ Tian-Yi Jiang
YP Yu-Fei Pan
ZW Zheng-Hua Wan
YL Yun-Kai Lin
BZ Bin Zhu
ZY Zhen-gang Yuan
YM Yun-Han Ma
YS Yuan-Yuan Shi
TZ Tian-Mei Zeng
LD Li-Wei Dong
YT Ye-Xiong Tan
HW Hong-Yang Wang
ask Ask a question
Favorite

The enzymatic activities of the proteasome were assayed using the Proteasome-Glo Cell-Based Assay Kit (Promega). The Proteasome-Glo Cell-Based Reagents each contain a specific luminogenic proteasome substrate in a buffer optimized for cell permeabilization, proteasome activity, and luciferase activity. These peptide substrates are Suc-LLVY-aminoluciferin (succinyl-leucine-leucine-valine-tyrosine-aminoluciferin), Z-LRR-aminoluciferin (Z-leucine-arginine-arginine-aminoluciferin), and Z-nLPnLD-aminoluciferin (Z-norleucine-proline-norleucine-aspartate-aminoluciferin) for chymotrypsin-like, trypsin-like, and caspase-like activities, respectively. The trypsin-like assay also contains two inhibitors to reduce nonspecific protease activities. Briefly, human CCA cells (5000 cells per well) were plated at 100 μl per well in a 96-well plate. The cells were then equilibrated at 37°C and 5% CO2 for 12 hours and subjected to different treatments. Then, the Proteasome-Glo Cell-Based Reagents were each prepared and equilibrated at 22°C for 30 min before use. During this time, the assay plate was also equilibrated. Fifteen minutes after adding the reagent, luminescence was detected as the relative light units using the Synergy 2 Multi-Mode Reader (BioTek). The data were normalized to the cell number using the CellTiter-Glo Luminescent Cell Viability Assay (Promega).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A